RecruitingNCT07185100

Determination of the Prevalence of Unrecognized Heart Failure Among Patients at Risk in Urban Areas Across Germany Using CMR

Studying Oculocerebral hypopigmentation syndrome, Cross type

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
German Heart Institute
Principal Investigator
Sebastian Kelle, Prof. Dr.
Deutsches Herzzentrum der Charité
Enrollment
600 target
Eligibility
40-69 years · All sexes
Timeline
20252036

Study locations (1)

Collaborators

AstraZeneca · Philips Healthcare · Deutsches Herzzentrum der Charité, Berlin · German Heart Center Foundation · Nationale Herzallianz (NHA) · Deutsche Herzstiftung

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07185100 on ClinicalTrials.gov

Other trials for Oculocerebral hypopigmentation syndrome, Cross type

Additional recruiting or active studies for the same condition.

See all trials for Oculocerebral hypopigmentation syndrome, Cross type

← Back to all trials